ARMP

Armata Pharmaceuticals, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$3.72

Price (1 Year)

$12.92 $3.28

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %149.4 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.

Website

Analysis (Turkish): ARMP Hissesi Caiz mi, Helal mi? Armata Pharmaceuticals, Inc. Katılım Analizi